
News|Articles|November 27, 2023
The value of Innovative Medicine: The clinical and economic impact of the first gene therapy for hemophilia B
Advertisement
Content provided by CSL Behring. Copyright 2023 and published by MJH Life Sciences®. No portion of this program may be reproduced or transmitted in any form, by any means, without the prior written permission of MJH Life Sciences. The views and opinions expressed in this material do not necessarily reflect the views and opinions of MJH Life Sciences, or Managed Healthcare Executive®.
Advertorial:
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Older drug could slash blood transfusions during surgeries | ASH 2025
2
Catheter ablation shows benefits for patients with both aFib and sleep apnea
3
2025 FDA dermatology approvals: A new gene therapy and two targeted therapies
4
Ultra-processed foods linked to early-onset colorectal adenomas in women
5

















































